About this trial
The aim of this study is to evaluate the effects of coronary thrombus modification on preventing the microvascular damage associated with primary percutaneous coronary intervention (PCI), and to limit the associated myocardial damage assessed by myocardial salvage index after 3 months. Furthermore, the project will evaluate coronary microvascular damage assessed invasively using both continuous and bolus thermodilution before and after stent implantation. In addition, the project will evaluate the diagnostic ability and associations of pre-stenting invasive physiological measurement to cardiac magnetic resonance imaging measurements.
Eligibility criteria
Qualifiers
ST-elevation at the J-junction in a minimum of two contiguous ECG leads with a minimum of ≥ 0.1 mV in all leads, except for V2 and V3 (which required ≥ 0.2 for men ≥ 40 years old, ≥ 0.25 in men < 40 years old, or ≥ 0.15 mV for all women) or new left bundle branch
Admission to hospital within 12 hours of symptom debut
Angiographic signs of a culprit lesion planned to be treated with primary percutaneous coronary intervention
Disqualifiers
Age < 18 years or inability to provide informed consent
Life expectancy of < 12 months
Hemodynamically instability
Pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- Coronary thrombus modification
- Standard stent implantation